Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Payables (2016 - 2026)

Skinvisible's Payables history spans 16 years, with the latest figure at $1.6 million for Q4 2025.

  • On a quarterly basis, Payables rose 86.93% to $1.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 86.93% increase, with the full-year FY2025 number at $1.6 million, up 86.93% from a year prior.
  • Payables hit $1.6 million in Q4 2025 for Skinvisible, up from $1.5 million in the prior quarter.
  • Over the last five years, Payables for SKVI hit a ceiling of $4.0 million in Q3 2022 and a floor of $166057.0 in Q1 2023.
  • Historically, Payables has averaged $1.8 million across 5 years, with a median of $1.5 million in 2025.
  • Biggest five-year swings in Payables: soared 2318.73% in 2021 and later plummeted 95.23% in 2023.
  • Tracing SKVI's Payables over 5 years: stood at $3.4 million in 2021, then tumbled by 63.71% to $1.2 million in 2022, then plummeted by 61.46% to $478668.0 in 2023, then skyrocketed by 79.45% to $858993.0 in 2024, then surged by 86.93% to $1.6 million in 2025.
  • Business Quant data shows Payables for SKVI at $1.6 million in Q4 2025, $1.5 million in Q3 2025, and $1.4 million in Q2 2025.